Celularity Inc
CELUW0.050USD
-0.000-0.20%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
0.00Cap. mercado
--P/E TTM
Más Datos de Celularity Inc Compañía
Celularity Inc. is a regenerative and cellular medicine company. It is developing and commercializing advanced biomaterial products and allogeneic, cryopreserved, placental-derived cell therapies, all derived from the postpartum placenta. Its therapeutic programs that target aging-related diseases, including degenerative diseases, cancer, and immune disorders, using mesenchymal-like adherent stromal cells, T-cells engineered with CAR (CAR T-cells), and genetically modified and unmodified natural killer (NK) cells. It develops, manufactures and commercializes advanced biomaterial products derived from structural tissue components of the postpartum placental tissues, including the umbilical cord. Its advanced biomaterials include Celularity Tendon Wrap, FUSE Bone Void Filler and Celularity Placental Matrix. Its advanced biomaterial products include Biovance, Interfyl and Rebound products. Its platform is Celularity IMPACT (Immuno-Modulatory Placental-derived Allogeneic Cell Therapy).
Información de la empresa
Símbolo de cotizaciónCELUW
Nombre de la empresaCelularity Inc
Fecha de salida a bolsaMay 23, 2019
Director ejecutivoDr. Robert J. (Bob) Hariri, M.D., Ph.D.
Número de empleados- -
Tipo de seguridadCompany Warrant
Fin del año fiscal- -
Dirección170 Park Ave
CiudadFLORHAM PARK
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal07932
Teléfono19087682170
Sitio Webhttps://celularity.com/
Símbolo de cotizaciónCELUW
Fecha de salida a bolsaMay 23, 2019
Director ejecutivoDr. Robert J. (Bob) Hariri, M.D., Ph.D.
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Joseph Dossantos
Mr. Joseph Dossantos
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Dr. Shiu Fei (Geoffrey) Ling, M.D., Ph.D.
Dr. Shiu Fei (Geoffrey) Ling, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Peter H. Diamandis, M.D.
Dr. Peter H. Diamandis, M.D.
Independent Director
Independent Director
--
--
Mr. John R. Haines
Mr. John R. Haines
Senior Executive Vice President, Chief Administrative Officer, Corporate Secretary
Senior Executive Vice President, Chief Administrative Officer, Corporate Secretary
--
--
Mr. Stephen A. Brigido
Mr. Stephen A. Brigido
President - Degenerative Disease
President - Degenerative Disease
--
--
Ms. Diane L. Parks
Ms. Diane L. Parks
Independent Director
Independent Director
--
--
Dr. Robert J. (Bob) Hariri, M.D., Ph.D.
Dr. Robert J. (Bob) Hariri, M.D., Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Carlos Ramirez
Mr. Carlos Ramirez
Senior Vice President - Investor Relations
Senior Vice President - Investor Relations
--
--
Mr. Vincent Levien
Mr. Vincent Levien
Director
Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Joseph Dossantos
Mr. Joseph Dossantos
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Dr. Shiu Fei (Geoffrey) Ling, M.D., Ph.D.
Dr. Shiu Fei (Geoffrey) Ling, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Peter H. Diamandis, M.D.
Dr. Peter H. Diamandis, M.D.
Independent Director
Independent Director
--
--
Mr. John R. Haines
Mr. John R. Haines
Senior Executive Vice President, Chief Administrative Officer, Corporate Secretary
Senior Executive Vice President, Chief Administrative Officer, Corporate Secretary
--
--
Mr. Stephen A. Brigido
Mr. Stephen A. Brigido
President - Degenerative Disease
President - Degenerative Disease
--
--
Ms. Diane L. Parks
Ms. Diane L. Parks
Independent Director
Independent Director
--
--
Desglose de ingresos
Sin datos
Sin datos
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: mié., 2 de jul
Actualizado: mié., 2 de jul
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Other
100.00%
Accionistas
Accionistas
Proporción
Other
100.00%
Tipos de accionistas
Accionistas
Proporción
Other
100.00%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
27
2.48M
0.00%
-1.91M
2025Q1
31
2.48M
0.00%
-2.12M
2024Q4
30
2.60M
0.00%
-2.17M
2024Q3
31
2.80M
0.00%
-1.78M
2024Q2
32
2.67M
0.00%
-2.18M
2024Q1
32
2.68M
0.00%
-2.18M
2023Q4
31
3.99M
0.00%
-892.77K
2023Q3
31
4.57M
0.00%
-1.21M
2023Q2
29
5.51M
0.00%
-1.17M
2023Q1
26
6.63M
0.00%
-928.95K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Walleye Capital LLC
850.11K
0%
-86.66K
-9.25%
Mar 31, 2025
Linden Advisors L.P.
550.12K
0%
--
--
Mar 31, 2025
Healthcare Of Ontario Pension Plan
350.00K
0%
--
--
Mar 31, 2025
Peak6 Capital Management LLC
171.36K
0%
--
--
Mar 31, 2025
Davidson Kempner Capital Management LP
150.80K
0%
--
--
Mar 31, 2025
Context Capital Management LLC
150.00K
0%
--
--
Mar 31, 2025
Shay Capital LLC
99.07K
0%
-47.76K
-32.53%
Mar 31, 2025
Corient Private Wealth LLC
55.00K
0%
--
--
Mar 31, 2025
EMFO, LLC
50.00K
0%
--
--
Jun 30, 2024
Clear Street LLC
11.91K
0%
-200.00
-1.65%
Mar 31, 2025
Ver más
ETFs relacionados
Nombre
Proporción
Sin datos
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
